BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10723479)

  • 1. [Skin and osteoarticular bacterial infections of the diabetic foot. Ulcers of the diabetic foot: epidemiology and physiopathology].
    Boutoille D; Leautez S; Maulaz D; Krempf M; Raffi F
    Presse Med; 2000 Feb; 29(7):389-92. PubMed ID: 10723479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing the incidence of foot ulceration and amputation in diabetes.
    Bartus CL; Margolis DJ
    Curr Diab Rep; 2004 Dec; 4(6):413-8. PubMed ID: 15539004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
    Boyko EJ; Ahroni JH; Stensel V; Forsberg RC; Davignon DR; Smith DG
    Diabetes Care; 1999 Jul; 22(7):1036-42. PubMed ID: 10388963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
    Adler AI; Boyko EJ; Ahroni JH; Smith DG
    Diabetes Care; 1999 Jul; 22(7):1029-35. PubMed ID: 10388962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering the risk of neuropathy, foot ulcers and amputations.
    Boulton AJ
    Diabet Med; 1998; 15 Suppl 4():S57-9. PubMed ID: 9868994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France.
    Malgrange D; Richard JL; Leymarie F;
    Diabetes Metab; 2003 Jun; 29(3):261-8. PubMed ID: 12909814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of factors favoring recurrent foot ulcers in diabetic patients].
    Diouri A; Slaoui Z; Chadli A; El Ghomari H; Kebbou M; Marouan F; Farouqi A; Ababou MR
    Ann Endocrinol (Paris); 2002 Dec; 63(6 Pt 1):491-6. PubMed ID: 12527849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of diabetic foot ulceration.
    Murray HJ; Boulton AJ
    Clin Podiatr Med Surg; 1995 Jan; 12(1):1-17. PubMed ID: 7720025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Critical analysis of vascular explorations in diabetic complications].
    Vayssairat M; Le Dévéhat C
    J Mal Vasc; 2001 Apr; 26(2):122-5. PubMed ID: 11319418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks?
    McNeely MJ; Boyko EJ; Ahroni JH; Stensel VL; Reiber GE; Smith DG; Pecoraro RF
    Diabetes Care; 1995 Feb; 18(2):216-9. PubMed ID: 7729300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.
    Zantour B; Bouchareb S; El Ati Z; Boubaker F; Alaya W; Kossomtini W; Sfar MH
    BMC Endocr Disord; 2020 Aug; 20(1):128. PubMed ID: 32831070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.
    Gershater MA; Löndahl M; Nyberg P; Larsson J; Thörne J; Eneroth M; Apelqvist J
    Diabetologia; 2009 Mar; 52(3):398-407. PubMed ID: 19037626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
    Reiber GE; Vileikyte L; Boyko EJ; del Aguila M; Smith DG; Lavery LA; Boulton AJ
    Diabetes Care; 1999 Jan; 22(1):157-62. PubMed ID: 10333919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diabetic foot: from art to science. The 18th Camillo Golgi lecture.
    Boulton AJ
    Diabetologia; 2004 Aug; 47(8):1343-53. PubMed ID: 15309286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diabetic foot: grand overview, epidemiology and pathogenesis.
    Boulton AJ
    Diabetes Metab Res Rev; 2008; 24 Suppl 1():S3-6. PubMed ID: 18442166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot.
    Lavery LA; Peters EJ; Williams JR; Murdoch DP; Hudson A; Lavery DC;
    Diabetes Care; 2008 Jan; 31(1):154-6. PubMed ID: 17934155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China.
    Jiang Y; Ran X; Jia L; Yang C; Wang P; Ma J; Chen B; Yu Y; Feng B; Chen L; Yin H; Cheng Z; Yan Z; Yang Y; Liu F; Xu Z
    Int J Low Extrem Wounds; 2015 Mar; 14(1):19-27. PubMed ID: 25573978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of clinical diabetic polyneuropathy in a Portuguese primary health care population.
    Barbosa AP; Medina JL; Ramos EP; Barros HP
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):496-502. PubMed ID: 11547224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?
    Carrington AL; Shaw JE; Van Schie CH; Abbott CA; Vileikyte L; Boulton AJ
    Diabetes Care; 2002 Nov; 25(11):2010-5. PubMed ID: 12401748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution and severity of diabetic foot disease: a community study with comparison to a non-diabetic group.
    Walters DP; Gatling W; Mullee MA; Hill RD
    Diabet Med; 1992 May; 9(4):354-8. PubMed ID: 1600707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.